Minimally Invasive Surgical Instruments Market | CAGR of 10.6%

<h2>Market Overview</h2>
<p>The Global <strong>Minimally Invasive Surgical Instruments Market size</strong> is expected to be worth around <strong>USD 86.8 Billion by 2032</strong>, from <strong>USD 35.1 Billion in 2023</strong>, growing at a <strong>CAGR of 10.6%</strong> during the forecast period from 2024 to 2033.</p>
<p>Minimally Invasive Surgical Instruments (MISI) are devices used to perform minimally invasive surgery, which involves smaller incisions and shorter recovery times. These instruments access organs through small, keyhole incisions, such as laparoscopic, arthroscopic, and robotic-assisted procedures.</p>
<p><a href="https://market.us/report/surgical-robotics-market/">Surgical robotics</a> has revolutionized minimally invasive surgery and is increasingly accepted by surgeons around the world. Minimally invasive surgery (MIS) costs are significantly lower than conventional open and in-patient surgeries. This results in significant value for both the patient and insurance companies. This trend will likely continue over the next few years.</p>
<p>The forecast period will see robust growth opportunities due to the increasing number of products being launched and product approvals from market players in order to gain a greater market share. In India, Abbott introduced a minimally invasive device to repair heart valves in 2020.</p>
<p><img class="size-full wp-image-108392 aligncenter" src="https://market.us/wp-content/uploads/2022/07/Minimally-Invasive-Surgical-Instruments-Market-Size-Forecast.jpg" alt="Minimally Invasive Surgical Instruments Market Size Forecast" width="1024" height="599"></p>

<h2>市场概览</h2>
<p>全球微创手术器械市场规模预计到2032年将达到约868亿美元，从2023年的351亿美元增长，在2024年至2033年预测期间以10.6%的复合年增长率增长。</p>
<p>微创手术器械（MISI）是用于实施微创手术的设备，此类手术涉及较小的切口和较短的恢复时间。这些器械通过小切口，如腹腔镜、关节镜和机器人辅助手术等，进入器官。</p>
<p><a href="https://market.us/report/surgical-robotics-market/">手术机器人</a>彻底改变了微创手术领域，并且正日益被全球外科医生所接受。微创手术（MIS）的成本显著低于传统开放式和住院手术。这对患者和保险公司都带来了巨大的价值。这种趋势预计在未来几年内将继续。</p>
<p>预测期间，由于产品数量增加和市场参与者为获取更大市场份额而进行的批准，将出现强劲的增长机会。2020年，印度Abbott公司推出了一款微创设备，用于修复心脏瓣膜。</p>